Cargando…
Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
BACKGROUND: An imbalance in the inflammatory tumor necrosis factor system, including soluble tumor necrosis factor receptor 2 (sTNFR2), may contribute to the pathophysiology of schizophrenia. METHODS: We measured the plasma levels of sTNFR2 in 256 healthy controls and 250 patients with schizophrenia...
Autores principales: | Kudo, Noriko, Yamamori, Hidenaga, Ishima, Tamaki, Nemoto, Kiyotaka, Yasuda, Yuka, Fujimoto, Michiko, Azechi, Hirotsugu, Niitsu, Tomihisa, Numata, Shusuke, Ikeda, Manabu, Iyo, Masaomi, Ohmori, Tetsuro, Fukunaga, Masaki, Watanabe, Yoshiyuki, Hashimoto, Kenji, Hashimoto, Ryota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031046/ https://www.ncbi.nlm.nih.gov/pubmed/29529289 http://dx.doi.org/10.1093/ijnp/pyy013 |
Ejemplares similares
-
Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020) -
S239. PREDICTIVE ACCURACY FOR WORK OUTCOME IN PATIENTS WITH SCHIZOPHRENIA
por: Sumiyoshi, Chika, et al.
Publicado: (2018) -
Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans
por: Steubl, Dominik, et al.
Publicado: (2017) -
Brain morphological and functional features in cognitive subgroups of schizophrenia
por: Yasuda, Yuka, et al.
Publicado: (2019) -
Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)